Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China Biopharmaceuticals Announces 2007 First Quarter Financial Results Conference Call 2007-05-21 21:00
Roll Up Your Sleeves, Japan! Sets Guinness World Record(TM) For Most Blood Pressure Readings in 24 Hours 2007-05-18 18:27
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack 2007-05-18 14:00
China Medicine Announces First Quarter 2007 Results 2007-05-17 11:00
China Biopharmaceuticals Holdings Announces First Quarter 2007 Financial Results 2007-05-16 23:41
Winner Medical Group Reports Second Quarter Fiscal 2007 Results 2007-05-16 20:30
Simcere Pharmaceutical Group Reports First Quarter 2007 Results 2007-05-16 06:00
China Pharma Holdings, Inc. Announces First Quarter 2007 Results 2007-05-15 20:00
First Patient Enrols in Aridol COPD Trial 2007-05-15 21:00
Mindray Medical International Announces First Quarter 2007 Results 2007-05-15 05:00
Mylan Laboratories to Acquire Generics Business of Merck KGaA 2007-05-14 16:40
Nick Colucci Named President and CEO of Publicis Healthcare Communications Group 2007-05-14 09:20
China Pharma Holdings, Inc. Announces Conference Call to Discuss First Quarter 2007 Results 2007-05-10 23:42
China Holdings, Inc. to Present at 3rd China Healthcare Industry Business Opportunity Trade Conference 2007-05-10 22:48
Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1) 2007-05-09 20:38
China Health Holding, Inc. Changes Name to China Holdings, Inc. 2007-05-09 21:48
New Regulatory Team at Quintiles Helps Bring Biotechnology Products to Market 2007-05-09 09:02
Singapore Attracts Four Major Biologics Manufacturing Investments Totaling Close to US$1 Billion in Less Than Two Years 2007-05-09 03:30
China Biopharmaceuticals Names New Officer and Directors 2007-05-08 10:21
3SBio Inc. to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference and the Merrill Lynch Pan Asia Rising Stars Conference 2007-05-08 09:59
1 790 791 792 793 794 801